Theranostics for Triple-Negative Breast Cancer
Diagnostics · 11.01.2023 · 13 (2) · 272
DOI: 10.3390/diagnostics13020272 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 11.01.2023. Verfasst von Hyeryeon Choi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Eulji Medical Center, Eulji University School of Medicine, Seoul 01830, Republic of Korea. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with poor prognosis. Current endocrine therapy or anti HER-2 therapy is not available for these patients. Chemotherapeutic treatment response varies among patients due to the disease heterogeneity. To overcome these challenges, theranostics for treating TNBC have been widely investigated. Anticancer material conjugated nanoparticles with target-binding ligand and tracer agents enable simultaneous drug delivery and visualization of the lesion with minimal off-target toxicity. In this review, we summarize recently FDA-approved targeted therapies for TNBC, such as poly-ADP-ribose polymerase (PARP) inhibitors, check point inhibitors, and antibody-drug conjugates. Particularly, novel theranostic approaches including lipid-based, polymer-based, and carbon-based nanocarriers are discussed, which can provide basic overview of nano-therapeutic modalities in TNBC diagnosis and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Eulji Medical Center, Eulji University School of Medicine, Seoul 01830, Republic of Korea.
- Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
ORCID-Profile: Hyeryeon Choi, Kwangsoon Kim
Zitieren
APA
Choi, H., & Kim, K. (2023). Theranostics for Triple-Negative Breast Cancer. Diagnostics, 13(2), 272. https://doi.org/10.3390/diagnostics13020272
Vancouver
Choi H, Kim K. Theranostics for Triple-Negative Breast Cancer. Diagnostics. 2023;13(2):272. doi:10.3390/diagnostics13020272
BibTeX
@article{Choi2023,
author = {Choi, Hyeryeon and Kim, Kwangsoon},
title = {Theranostics for Triple-Negative Breast Cancer},
journal = {Diagnostics},
year = {2023},
volume = {13},
number = {2},
pages = {272},
doi = {10.3390/diagnostics13020272}
}
EUVIMED